Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA REVITALIZATION ACT COULD PASS VIA FISCAL 1989 APPROPRIATIONS BILL

Executive Summary

FDA REVITALIZATION ACT COULD PASS VIA FISCAL 1989 APPROPRIATIONS BILL, under an agreement between Sen. Hatch (R-Utah) and Labor & Human Resources Committee Chairman Kennedy (D-Mass.). In June 6 letter to Senate Agriculture appropriations Subcommittee Chairman Burdick (D-N.D.), Kennedy and Hatch asked the seven provisions in S 2468 be included in the FDA appropriation for 1989. Kennedy reportedly has indicated that the Hatch bill's federal preemption/uniformity and de minimis provisions should not circumvent the legislative process and that he will consider scheduling Labor & Human Resources Committee action on those subjects separately. Kennedy, however, agrees with Hatch on seeking the appropriations process for seven provisions: (1) Planning a "consolidated" FDA Washington facility; (2) establishing a senior biomedical scientist service; (3) increasing agency staff; (4) funds to help FDA facilitate approvals for small businesses; (5) funding for demonstration projects for developing public or private cooperatives; (6) funding for scientist training grants; and (7) authorizing FDA appointment of scientific peer review groups. Kennedy's quick support for the FDA revitalization proposal brings the Massachusetts Democrat back into the FDA area. In the late 1970's, Kennedy proposed a bill which would have broken the agency into several separate agencies.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS013795

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel